← Open Payments lookup

URSULA CABAUATAN: Open Payments

NPI 1245814136 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$643 in 23 payments from 13 companies in 2025. Trend: 2023 $532 · 2024 $1,454 · 2025 $643

Food & beverage: $544Education: $99
CompanyPaymentsAmount
Gilead Sciences, Inc.6$197
Daiichi Sankyo Inc.2$124
Janssen Biotech, Inc.3$61
Syndax Pharmaceuticals, Inc.2$60
Eisai Inc.2$33
Lilly USA, LLC1$32
Stemline Therapeutics Inc.1$24
Genmab U.S., Inc.1$21
Azurity Pharmaceuticals, Inc.1$20
TAIHO ONCOLOGY, INC.1$19

Products named: Trodelvy, Enhertu, ERLEADA, Lenvima, VERZENIO, Orserdu, Epkinly, DANZITEN.

Industry payments across TX — which companies pay providers there.